Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease (Q37554366)

21 August 2017

Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

21 August 2017

0 references

0 references

0 references

3

Marla Dubinsky

0 references

Sarah C Glover

object named as

Sarah Glover

8

0 references

Antoine Cortot

object named as

Antoine Cortot

4

0 references

David T Rubin

10

object named as

David T Rubin

1 reference

21 August 2017

Uma Mahadevan

1

1 reference

21 August 2017

Douglas C Wolf

2

1 reference

21 August 2017

Marla Dubinsky

3

1 reference

21 August 2017

Scott D Lee

5

1 reference

21 August 2017

Corey A Siegel

6

1 reference

21 August 2017

Thomas Ullman

7

1 reference

21 August 2017

John F Valentine

9

1 reference

21 August 2017

Jocelyn Miller

11

1 reference

21 August 2017

Maria T Abreu

12

1 reference

21 August 2017

language of work or name

English

0 references

publication date

28 November 2012

1 reference

Clinical Gastroenterology and Hepatology

21 August 2017

1 reference

21 August 2017

11

1 reference

21 August 2017

286-92; quiz e24

1 reference

21 August 2017

3

1 reference

IgG placental transfer in healthy and pathological pregnancies

21 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913646

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913646

Preterm birth and neurodevelopmental outcome: a review

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913646

A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration database

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913646

Certolizumab pegol for the treatment of Crohn's disease

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913646

Disease activity in pregnant women with Crohn's disease and birth outcomes: a regional Danish cohort study

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913646

Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913646

Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913646

Placental transport of immunoglobulin G.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913646

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913646

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and pediatrics

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913646

Detection of infliximab in breast milk of nursing mothers with inflammatory bowel disease.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913646

Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913646

Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's disease.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913646

Absence of infliximab in infants and breast milk from nursing mothers receiving therapy for Crohn's disease before and after delivery

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913646

Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913646

Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913646

The successful use of adalimumab to treat active Crohn's disease of an ileoanal pouch during pregnancy.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913646

Adalimumab use in pregnancy

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913646

Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3913646

Adalimumab level in breast milk of a nursing mother

3 December 2018

1 reference

12 December 2020

High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy

1 reference

12 December 2020

Successful use of adalimumab (Humira) for Crohn's disease in pregnancy

1 reference

12 December 2020

Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis

1 reference

12 December 2020

10.1016/J.CGH.2012.11.011

Identifiers

DOI

1 reference

21 August 2017

1 reference

21 August 2017

1 reference